Interactive Provincial Explorer
Age-standardized incidence rate per 100,000 population (data for 2022, reflecting observed trends from 1992-2022 and projections to 2028). Highlighted bar is Canada.
Incidence rate per 100,000 for All Cancers in All Genders (data for 2022, reflecting observed trends from 1992-2022 and projections to 2028).
In Canada, as across the nation, the story is often twofold: overall cancer risk (age-standardized rate) may show certain trends, but the total number of people affected by cancer can be influenced by population aging and growth. This creates dynamic pressures on the healthcare system. Specific trends vary significantly by cancer type, demographic factors, and region. The data presented here for 2022 (within the selected 2018-2022 period) should be understood within the context of observed trends from 1992-2022 and projections extending to 2028.
What Drives These Differences?
Socioeconomic status significantly impacts cancer outcomes. Disparities in income and education correlate with higher rates for some cancers, often due to lifestyle factors, occupational exposures, and challenges in accessing timely screening and specialized care, particularly highlighting urban-rural divides.
Regional differences matter. Over 90% of environmental cancers in Ontario are linked to UV radiation, radon, and air pollution. Northern regions see higher occupational exposures, posing localized risks.
Smoking, obesity, and alcohol use are major drivers of cancer risk. Their prevalence varies by region and socioeconomic status, explaining some of the historic East-West divide in cancer rates.
Pathways to Progress: Policy & Interventions
Tailoring prevention, screening, and treatment to provincial needs, including investing in digital health infrastructure to bridge access gaps for remote and underserved populations.
Developing and implementing cancer control initiatives that are specifically designed for different age groups, considering their varying risk factors and healthcare needs.
Recognizing and addressing the differences in cancer incidence, risk factors, and responses to treatment between genders to optimize public health strategies.